Category
Cancer
Sub Category
Lung
Study Name
Synta Galaxy-2: 9090-14 A Randomized, Phase 3 Study of Ganetespib in Combination with Docetaxel Versus Docetaxel Alone in Patients with Advances Non-small-Cell Adenocarcinoma
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance